L701-0608 Screening compound: 1-(morpholin-4-yl)-3-{5-[5-(1-phenylcyclopropyl)-1,2,4-oxadiazol-3-yl]-1H-1,2,3-benzotriazol-1-yl}propan-1-one

L701-0608 Screening compound: 1-(morpholin-4-yl)-3-{5-[5-(1-phenylcyclopropyl)-1,2,4-oxadiazol-3-yl]-1H-1,2,3-benzotriazol-1-yl}propan-1-one
L701-0608 Screening compound: 1-(morpholin-4-yl)-3-{5-[5-(1-phenylcyclopropyl)-1,2,4-oxadiazol-3-yl]-1H-1,2,3-benzotriazol-1-yl}propan-1-one alternative view

Chemical Structure Depiction of ChemDiv screening compound L701-0608
1-(morpholin-4-yl)-3-{5-[5-(1-phenylcyclopropyl)-1,2,4-oxadiazol-3-yl]-1H-1,2,3-benzotriazol-1-yl}propan-1-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L701-0608

Molecular Formula

C24H24N6O3 (C24 H24 N6 O3)

Compound Name

1-(morpholin-4-yl)-3-{5-[5-(1-phenylcyclopropyl)-1,2,4-oxadiazol-3-yl]-1H-1,2,3-benzotriazol-1-yl}propan-1-one

IUPAC name

1-(morpholin-4-yl)-3-{5-[5-(1-phenylcyclopropyl)-124-oxadiazol-3-yl]-1H-123-benzotriazol-1-yl}propan-1-one

SMILES

O=C(CCn1nnc2c1ccc(-c1noc(C3(CC3)c3ccccc3)n1)c2)N1CCOCC1

InChI

InChI=1S/C24H24N6O3/c31-21(29-12-14-32-15-13-29)8-11-30-20-7-6-17(16-19(20)26-28-30)22-25-23(33-27-22)24(9-10-24)18-4-2-1-3-5-18/h1-7,16H,8-15H2

InChI Key

IYKZUQMTTOWUIX-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27470973

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

444.49

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

2.440

Distribution Coefficient, logD

2.440

Water Solubility, LogSw

-2.84

Polar Surface Area

81.601

Acid Dissociation Constant (pKa)

22.14

Base Dissociation Constant (pKb)

-0.61

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

37.50

L701-0608 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

PI3K-Targeted Library (17255 compounds)

Targeted Diversity Library (40567 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with L701-0608 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L701-0608?
Check Price and Availability of L701-0608, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L701-0608 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L701-0608
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L701-0608
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L701-0608 available by request